Leerink
Swann, the leading healthcare-focused investment banking firm, today
announced the availability of the firm’s 2010 healthcare investment
outlook report.
Investment analysis for 2010 is provided in the following healthcare
sectors: Healthcare Strategy, Biotechnology, Healthcare Services -
Managed Care/Facilities, Healthcare Technology & Distribution, Life
Science Tools & Diagnostics and Medical Supplies & Devices
Pharmaceuticals/Major and Specialty. Key highlights include:
● Expect most healthcare sectors to outperform in 2010 after a
lackluster 2009.
● Attractive relative earnings growth and valuations should drive
investor rotation into healthcare as the reform legislation overhang
lifts.
● Focus first on the liquid large therapeutics and managed care
companies, as well as other sectors discussed in the report.